| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |